3rd Quarter - Amendment

ACG ADVOCACY for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 20, 2015 $50,000 Replaced
3rd Quarter - Amendment (this page) Jul 19, 2016 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Rebates for dual eligible and low-income subsidy population in Medicare Part D. Non-Interference. 21st Century Cures.

LobbyistCovered position, as disclosed
STUART CHAPMAN —
SHERYL COHEN —
CHRIS ISRAEL —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Cost Sharing (Preserving Access to Medicines). Healthcare Exchanges. Average Sales Price. Reimbursements. CHIP.

LobbyistCovered position, as disclosed
STUART CHAPMAN Chief of Staff, Rep. Carolyn McCarthy; Chief of Staff, Rep. Zack Space; Press Secretary, Senator Jay Rockefeller; Press Secretary,Rep. Barbara Lee
SHERYL COHEN Chief of Staff, Senator Christopher Dodd; Political Director, Senator Christopher Dodd; Finance Director, Senator Joe Lieberman
CHRIS ISRAEL U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce
STEPHEN PINKOS Policy Director/General Counsel, House Majority Whip Kevin McCarthy; Deputy Undersecretary of Commerce for IP; Staff Director, House Judiciary Committee

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.